Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Enveric Biosciences Inc.

    NASDAQ: ENVB · Real-Time Price · USD
    1.27
    -0.02 (-1.55%)
    At close: Jun 05, 2025, 3:59 PM
    1.25
    -1.96%
    After-hours: Jun 05, 2025, 07:39 PM EDT

    Enveric Biosciences Statistics

    Share Statistics

    Enveric Biosciences has 2.47M shares outstanding. The number of shares has increased by -75.33% in one year.

    Shares Outstanding

    n/a
    		 2.47M

    Shares Change (YoY)

    n/a
    		 -75.33%

    Shares Change (QoQ)

    n/a
    		 -81.2%

    Owned by Institutions (%)

    n/a
    		 12.4%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 2,136

    FTD / Avg. Volume

    n/a
    		 1.09%

    Short Selling Information

    The latest short interest is 125.15K, so 5.06% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 125.15K

    Short % of Shares Out

    n/a
    		 5.06%

    Short % of Float

    n/a
    		 5.11%

    Short Ratio (days to cover)

    n/a
    		 2.28

    Valuation Ratios

    The PE ratio is -0.28 and the forward PE ratio is -0.05. Enveric Biosciences's PEG ratio is 0.

    PE Ratio

    n/a
    		 -0.28

    Forward PE

    n/a
    		 -0.05

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.1

    PB Ratio

    n/a
    		 1.7

    P/FCF Ratio

    n/a
    		 -0.35

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Enveric Biosciences.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 1.84, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 1.84

    Quick Ratio

    n/a
    		 1.84

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,914,997.4

    Employee Count

    n/a
    		 5

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 8.93K

    Effective Tax Rate

    n/a
    		 -0.09%

    Stock Price Statistics

    The stock price has increased by -88.8% in the last 52 weeks. The beta is 0.52, so Enveric Biosciences's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.52

    52-Week Price Change

    n/a
    		 -88.8%

    50-Day Moving Average

    n/a
    		 1.29

    200-Day Moving Average

    n/a
    		 4.26

    Relative Strength Index (RSI)

    n/a
    		 50.21

    Average Volume (20 Days)

    n/a
    		 195,177

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -9.63M

    Net Income

    n/a
    		 -9.57M

    EBITDA

    n/a
    		 -9.23M

    EBIT

    n/a
    		 -9.57M

    Earnings Per Share (EPS)

    n/a
    		 -19.04
    Full Income Statement

    Balance Sheet

    The company has 2.24M in cash and 0 in debt, giving a net cash position of 2.24M.

    Cash & Cash Equivalents

    n/a
    		 2.24M

    Total Debt

    n/a
    		 n/a

    Net Cash

    n/a
    		 n/a

    Retained Earnings

    n/a
    		 -106.07M

    Total Assets

    n/a
    		 5.1M

    Working Capital

    n/a
    		 3.65M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -7.73M and capital expenditures 0, giving a free cash flow of -7.73M.

    Operating Cash Flow

    n/a
    		 -7.73M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -7.73M

    FCF Per Share

    n/a
    		 -15.36
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    ENVB does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for ENVB is $10, which is 663.4% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $10

    Price Target Difference

    n/a
    		 663.4%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 1
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jul 15, 2022. It was a backward split with a ratio of 1:50.

    Last Split Date

    n/a
    		 Jul 15, 2022

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:50

    Scores

    Altman Z-Score

    n/a
    		 -33.39

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist